Historique
Bulletin de Périodique
Addiction , Vol.117, n°6 - June 2022
Paru le :
01/06/2022
Année :
2022
Page(s) :
1505-1823
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Low- and very low-dose buprenorphine induction: new(ish) uses for an old(ish) medication? [Editorial]. Weimer M.B., Fiellin D.A., p. 1507-1509.
- The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use [Addiction opinion and debate]. Lorenzetti V., Hindocha C., Petrilli K., Griffiths P., Brown J., Castillo-Carniglia A., et al., p. 1510-1517.
- The need to calibrate standardized cannabis measurements across cultures. Kuhns L., Kroon E., p. 1518-1519.
- Coordinating cannabis data collection globally: Policy implications. Weiss S.R.B., Volkow N.D., p. 1520-1521.
- We need convincing data to support a public health approach to cannabis regulation. Jesseman R., p. 1521-1523.
- The iCannToolkit: a tool to embrace measurement of medicinal and non-medicinal cannabis use across licit, illicit and cross-cultural settings. Lorenzetti V., Hindocha C., Petrilli K., Griffiths P., Brown J., Castillo-Carniglia A., et al., p. 1523-1525.
- A systematic review of behavioural smoking cessation interventions for people with severe mental ill health-what works? Spanakis P., Peckham E., Young B., Heron P., Bailey D., Gilbody S., p. 1526-1542.
- Associations of common mental disorder with alcohol use in the adult general population: a systematic review and meta-analysis. Puddephatt J.A., Irizar P., Jones A., Gage S.H., Goodwin L., p. 1543-1572.
- Effects of interventions to combat tobacco addiction: Cochrane update of 2019 and 2020 reviews. Livingstone-Banks J., Lindson N., Hartmann-Boyce J., Aveyard P., p. 1573-1588.
- The association between involuntary alcohol treatment and subsequent emergency department visits and hospitalizations: a Bayesian analysis of treated patients and matched controls. Vuong T., Gillies M., Larney S., Montebello M., Ritter A., p. 1589-1597.
- Is lower severity alcohol use disorder qualitatively different than more severe manifestations? An evaluation of multivariate symptom clusters. Bailey A.J., Ingram P.F., Howe L.K., Finn P.R., p. 1598-1608.
- Efficacy of a theory-driven program to implement alcohol screening and brief interventions in primary health-care: a cluster randomized controlled trial. Rosário F., Vasiljevic M., Pas L., Angus C., Ribeiro C., Fitzgerald N., p. 1609-1621.
- The impact of changes in COVID-19 lockdown restrictions on alcohol consumption and drinking occasion characteristics in Scotland and England in 2020: an interrupted time-series analysis. Hardie I., Stevely A.K., Sasso A., Meier P.S., Holmes J., p. 1622-1639.
- Prevalence of alcohol use disorders in primary health-care facilities in Russia in 2019. Rehm J., Shield K.D., Bunova A., Ferreira-Borges C., Franklin A., Gornyi B., et al., p. 1640-1646.
- Alcohol consumption patterns and growth differentiation factor 15 among life-time drinkers aged 65+?years in Spain: a cross-sectional study. Ortola R., Garcia-Esquinas E., Buno-Soto A., Carballo-Casla A., Sotos-Prieto M., Banegas J.R., et al., p. 1647-1657.
- Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double-dummy, randomised, controlled trial. Skulberg A.K., Tylleskär I., Valberg M., Braarud A.C., Dale J., Heyerdahl F., et al., p. 1658-1667.
- Commentary on Skulberg et al.: Naloxone administration - finding the balance. Jauncey M., Bartlett M., Roxburgh A., p. 1668-1669.
- Ongoing HIV transmission following a large outbreak among people who inject drugs in Athens, Greece (2014-20). Roussos S., Paraskevis D., Psichogiou M., Kostaki E.G., Flountzi E., Angelopoulos T., et al., p. 1670-1682.
- Real-world effectiveness of pharmacological treatments of opioid use disorder in a national cohort. Heikkinen M., Taipale H., Tanskanen A., Mittendorfer-Rutz E., Lähteenvuo M., Tiihonen J., p. 1683-1691.
- Drug overdoses during the COVID-19 pandemic among recently homeless individuals. Liu M., Richard L., Campitelli M.A., Nisenbaum R., Dosani N., Dhalla I.A., et al., p. 1692-1701.
- Gambling and homelessness in older adults: a qualitative investigation. Vandenberg B., Livingstone C., Carter A., O'Brien K., p. 1702-1712.
- Commentary on Vandenberg et al.: The next step of developing and testing evidence-based interventions for older adults who experience problem gambling and homelessness. Woodhall-Melnik J., Matheson F.I., p. 1713-1714.
- Does sex alter the relationship between CYP2B6 variation, hydroxybupropion concentration and bupropion-aided smoking cessation in African Americans? A moderated mediation analysis. Chenoweth M.J., Peng A.R., Zhu A.Z.X., Cox L.S., Nollen N.L., Ahluwalia J.S., et al., p. 1715-1724.
- Commentary on Chenoweth et al.: Assessing response to interventions for smoking cessation in diverse populations. Young K.A., Hokanson J.E., p. 1725-1726.
- Smoking trajectories from adolescence to early adulthood as a longitudinal predictor of mental health in adulthood: evidence from 21?years of a nationally representative cohort. Lee B., Levy D.E., Macy J.T., Elam K.K., Bidulescu A., Seo D.C., p. 1727-1736.
- Standardised packs and larger health warnings: visual attention and perceptions among Colombian smokers and non-smokers. Sillero-Rejon C., Mahmoud O., Tamayo R.M., Clavijo-Alvarez A.A., Adams S., Maynard O.M., p. 1737-1747.
- Planning a Change Easily (PACE) for smokers who are not ready to quit: a telephone-based, randomized controlled trial. Derefinko K.J., Bursac Z., Hand S.B., Ebbert J.O., Womack C., Klesges R.C., p. 1748-1757.
- Effect of a workplace mobile phone-based instant messaging intervention on smoking cessation: a cluster-randomized controlled trial. Weng X., Lau O.S., Ng C.H., Li W.H.C., Lam T.H., Wang M.P., p. 1758-1767.
- A difference-in-difference approach to examining the impact of cannabis legalization on disparities in the use of cigarettes and cannabis in the United States, 2004-17. Weinberger A.H., Wyka K., Kim J.H., Smart R., Mangold M., Schanzer E., et al., p. 1768-1777.
- Commentary on Weinberger et al.: Tobacco and cannabis policies as drivers of nicotine and cannabis co-use - research and measurement implications to move the field forward. Philbin M.M., Giovenco D.P., Mauro P.M., p. 1778-1780.
- The estimated impact of state-level support for expanded delivery of substance use disorder treatment during the COVID-19 pandemic. Nesoff E.D., Marziali M.E., Martins S.S., p. 1781-1786.
- Did the under-reporting of meth/amphetamine use increase in a general population survey in Australia as negative media coverage increased? Chan G.C.K., Sun T., Lim C., Stjepanovic D., Rutherford B., Johnson B., et al., p. 1787-1793.
- Mental health conditions and receipt of mental health care by illicit lysergic acid diethylamide (LSD) use status among young adults in the United States. Han B., Blanco C., Einstein E.B., Compton W.M., p. 1794-1800.
- Tobacco use during pregnancy. Havard A., Chandran J.J., Oei J.L., p. 1801-1810.
- Aldous Huxley's The Doors of Perception. Hall W., Farrell M., p. 1811-1815.
- Stigma and gaming disorder: should we take a 'glass half full' or 'glass half empty' perspective? Pontes H.M., Montag C., Elhai J.D., Monteiro A.V., Evren C., Throuvala M.A., et al., p. 1816-1817.
- Commentary on Krans et al.: Outcomes associated with the use of medications for opioid use disorder during pregnancy. Schmidt R.A., p. 1818-1819.
- Low- and very low-dose buprenorphine induction: new(ish) uses for an old(ish) medication? [Editorial]. Weimer M.B., Fiellin D.A., p. 1507-1509.
- The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use [Addiction opinion and debate]. Lorenzetti V., Hindocha C., Petrilli K., Griffiths P., Brown J., Castillo-Carniglia A., et al., p. 1510-1517.
- The need to calibrate standardized cannabis measurements across cultures. Kuhns L., Kroon E., p. 1518-1519.
- Coordinating cannabis data collection globally: Policy implications. Weiss S.R.B., Volkow N.D., p. 1520-1521.
- We need convincing data to support a public health approach to cannabis regulation. Jesseman R., p. 1521-1523.
- The iCannToolkit: a tool to embrace measurement of medicinal and non-medicinal cannabis use across licit, illicit and cross-cultural settings. Lorenzetti V., Hindocha C., Petrilli K., Griffiths P., Brown J., Castillo-Carniglia A., et al., p. 1523-1525.
- A systematic review of behavioural smoking cessation interventions for people with severe mental ill health-what works? Spanakis P., Peckham E., Young B., Heron P., Bailey D., Gilbody S., p. 1526-1542.
- Associations of common mental disorder with alcohol use in the adult general population: a systematic review and meta-analysis. Puddephatt J.A., Irizar P., Jones A., Gage S.H., Goodwin L., p. 1543-1572.
- Effects of interventions to combat tobacco addiction: Cochrane update of 2019 and 2020 reviews. Livingstone-Banks J., Lindson N., Hartmann-Boyce J., Aveyard P., p. 1573-1588.
- The association between involuntary alcohol treatment and subsequent emergency department visits and hospitalizations: a Bayesian analysis of treated patients and matched controls. Vuong T., Gillies M., Larney S., Montebello M., Ritter A., p. 1589-1597.
- Is lower severity alcohol use disorder qualitatively different than more severe manifestations? An evaluation of multivariate symptom clusters. Bailey A.J., Ingram P.F., Howe L.K., Finn P.R., p. 1598-1608.
- Efficacy of a theory-driven program to implement alcohol screening and brief interventions in primary health-care: a cluster randomized controlled trial. Rosário F., Vasiljevic M., Pas L., Angus C., Ribeiro C., Fitzgerald N., p. 1609-1621.
- The impact of changes in COVID-19 lockdown restrictions on alcohol consumption and drinking occasion characteristics in Scotland and England in 2020: an interrupted time-series analysis. Hardie I., Stevely A.K., Sasso A., Meier P.S., Holmes J., p. 1622-1639.
- Prevalence of alcohol use disorders in primary health-care facilities in Russia in 2019. Rehm J., Shield K.D., Bunova A., Ferreira-Borges C., Franklin A., Gornyi B., et al., p. 1640-1646.
- Alcohol consumption patterns and growth differentiation factor 15 among life-time drinkers aged 65+?years in Spain: a cross-sectional study. Ortola R., Garcia-Esquinas E., Buno-Soto A., Carballo-Casla A., Sotos-Prieto M., Banegas J.R., et al., p. 1647-1657.
- Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double-dummy, randomised, controlled trial. Skulberg A.K., Tylleskär I., Valberg M., Braarud A.C., Dale J., Heyerdahl F., et al., p. 1658-1667.
- Commentary on Skulberg et al.: Naloxone administration - finding the balance. Jauncey M., Bartlett M., Roxburgh A., p. 1668-1669.
- Ongoing HIV transmission following a large outbreak among people who inject drugs in Athens, Greece (2014-20). Roussos S., Paraskevis D., Psichogiou M., Kostaki E.G., Flountzi E., Angelopoulos T., et al., p. 1670-1682.
- Real-world effectiveness of pharmacological treatments of opioid use disorder in a national cohort. Heikkinen M., Taipale H., Tanskanen A., Mittendorfer-Rutz E., Lähteenvuo M., Tiihonen J., p. 1683-1691.
- Drug overdoses during the COVID-19 pandemic among recently homeless individuals. Liu M., Richard L., Campitelli M.A., Nisenbaum R., Dosani N., Dhalla I.A., et al., p. 1692-1701.
- Gambling and homelessness in older adults: a qualitative investigation. Vandenberg B., Livingstone C., Carter A., O'Brien K., p. 1702-1712.
- Commentary on Vandenberg et al.: The next step of developing and testing evidence-based interventions for older adults who experience problem gambling and homelessness. Woodhall-Melnik J., Matheson F.I., p. 1713-1714.
- Does sex alter the relationship between CYP2B6 variation, hydroxybupropion concentration and bupropion-aided smoking cessation in African Americans? A moderated mediation analysis. Chenoweth M.J., Peng A.R., Zhu A.Z.X., Cox L.S., Nollen N.L., Ahluwalia J.S., et al., p. 1715-1724.
- Commentary on Chenoweth et al.: Assessing response to interventions for smoking cessation in diverse populations. Young K.A., Hokanson J.E., p. 1725-1726.
- Smoking trajectories from adolescence to early adulthood as a longitudinal predictor of mental health in adulthood: evidence from 21?years of a nationally representative cohort. Lee B., Levy D.E., Macy J.T., Elam K.K., Bidulescu A., Seo D.C., p. 1727-1736.
- Standardised packs and larger health warnings: visual attention and perceptions among Colombian smokers and non-smokers. Sillero-Rejon C., Mahmoud O., Tamayo R.M., Clavijo-Alvarez A.A., Adams S., Maynard O.M., p. 1737-1747.
- Planning a Change Easily (PACE) for smokers who are not ready to quit: a telephone-based, randomized controlled trial. Derefinko K.J., Bursac Z., Hand S.B., Ebbert J.O., Womack C., Klesges R.C., p. 1748-1757.
- Effect of a workplace mobile phone-based instant messaging intervention on smoking cessation: a cluster-randomized controlled trial. Weng X., Lau O.S., Ng C.H., Li W.H.C., Lam T.H., Wang M.P., p. 1758-1767.
- A difference-in-difference approach to examining the impact of cannabis legalization on disparities in the use of cigarettes and cannabis in the United States, 2004-17. Weinberger A.H., Wyka K., Kim J.H., Smart R., Mangold M., Schanzer E., et al., p. 1768-1777.
- Commentary on Weinberger et al.: Tobacco and cannabis policies as drivers of nicotine and cannabis co-use - research and measurement implications to move the field forward. Philbin M.M., Giovenco D.P., Mauro P.M., p. 1778-1780.
- The estimated impact of state-level support for expanded delivery of substance use disorder treatment during the COVID-19 pandemic. Nesoff E.D., Marziali M.E., Martins S.S., p. 1781-1786.
- Did the under-reporting of meth/amphetamine use increase in a general population survey in Australia as negative media coverage increased? Chan G.C.K., Sun T., Lim C., Stjepanovic D., Rutherford B., Johnson B., et al., p. 1787-1793.
- Mental health conditions and receipt of mental health care by illicit lysergic acid diethylamide (LSD) use status among young adults in the United States. Han B., Blanco C., Einstein E.B., Compton W.M., p. 1794-1800.
- Tobacco use during pregnancy. Havard A., Chandran J.J., Oei J.L., p. 1801-1810.
- Aldous Huxley's The Doors of Perception. Hall W., Farrell M., p. 1811-1815.
- Stigma and gaming disorder: should we take a 'glass half full' or 'glass half empty' perspective? Pontes H.M., Montag C., Elhai J.D., Monteiro A.V., Evren C., Throuvala M.A., et al., p. 1816-1817.
- Commentary on Krans et al.: Outcomes associated with the use of medications for opioid use disorder during pregnancy. Schmidt R.A., p. 1818-1819.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection![The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use [Addiction opinion and debate]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_84963.webp)
V. LORENZETTI ;
C. HINDOCHA ;
K. PETRILLI ;
P. GRIFFITHS ;
J. BROWN ;
A. CASTILLO-CARNIGLIA ;
J. P. CAULKINS ;
A. ENGLUND ;
M. A. ElSOHLY ;
S. H. GAGE ;
T. GROSHKOVA ;
A. GUAL ;
D. HAMMOND ;
W. LAWN ;
H. LOPEZ-PELAYO ;
J. MANTHEY ;
C. MOKRYSZ ;
R. L. PACULA ;
M. VAN LAAR ;
R. VANDREY ;
E. WADSWORTH ;
A. WINSTOCK ;
W. HALL ;
H. V. CURRAN ;
T. P. FREEMAN
|
2022
Dans Addiction (Vol.117, n°6, June 2022) Article : Périodique
Dans Addiction (Vol.117, n°6, June 2022) Article : Périodique
BACKGROUND: The lack of an agreed international minimum approach to measuring cannabis use hinders the integration of multidisciplinary evidence on the psychosocial, neurocognitive, clinical and public health consequences of cannabis use.
METH[...]